Stocks-CPRX-Catalyst Pharmaceuticals Inc

CPRX Catalyst Pharmaceuticals Inc

20.20 0.29 (1.46%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Stocks-CPRX-Catalyst Pharmaceuticals Inc
CPRX Catalyst Pharmaceuticals Inc
Trade

Overview

Prev Close 20.20
Day's Range 19.67 - 20.20
52 Week Range 11.86 - 21.58
Average Volume (3M) 990.3K
1-Year Return 57.78%
Beta1.0589
Market Cap 2.4B
P/E Ratio37.86
Revenue434.48M
EPS0.5335
Dividend (Yield) 0 (0%)
Sector
Health Technology
Industry
Pharmaceuticals Major
CEO
Richard John Daly, MBA
Employees
167

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Catalyst Pharmaceuticals Inc's revenues increased by 85.90% and amounted to 398.20M. Net income decreased by 14.05% to 71.41M. Net assets increased by 29.11% to 387.88M and EPS decreased from 0.75 to 0.63.
CPRX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Created with Highcharts 4.2.7 /Highstock 4.2.7Total RevenueNet Income09/2312/2303/2406/24-50M050M100M150M
Gross Margin
78.33%
Net Profit Margin
35.78%
Operating Margin
19.77%
Return On Investment
28.93%
09/23
12/23
03/24
06/24
Total Revenue
102.69M
110.57M
98.51M
122.71M
Gross Profit
80.03M
85.7M
76.65M
97.96M
Operating Income
-37.19M
41.69M
27.13M
54.25M
Net Income
-30.76M
34.84M
23.28M
40.79M